首页> 外文期刊>VASA: Zeitschrift fuer Gefarsskrankheiten. Journal for vascular diseases >Microcirculatory and clinical effects of serial percutaneous application of carbon dioxide in primary and secondary Raynaud's phenomenon.
【24h】

Microcirculatory and clinical effects of serial percutaneous application of carbon dioxide in primary and secondary Raynaud's phenomenon.

机译:在原发性和继发性雷诺现象中,连续经皮应用二氧化碳的微循环和临床效果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: A randomized double-blind monocentric trial was conducted at the spa of Royat, France, in patients with mild Raynaud's phenomenon (one or two attacks a day during the autumn and winter months). Hemodynamic changes were quantified by laser Doppler flow (LDF) and computerized chronothermometric test (CT) during local application of CO2 and compared with the usual clinical parameters. PATIENTS AND METHODS: Patients were randomized to 18 days of CO2 (group 1) or 9 days of air + 9 days of CO2 (group 2). The gas was applied at a constant temperature to previously humidified skin on the forearm. Effects of the active treatment were measured by LDF and continuing benefits by computerized chronothermometric test (CT test). Clinical assessment was made on four occasions (before, in the middle and at the end of treatment, and three months afterwards) on the basis of the number of daily attacks and the duration and severity of the attacks. RESULTS: LDF showed a significant increase in digital blood flow (+ 41%) and in vasomotion (+ 42%) during CO2 treatment but no change on placebo treatment. CT test showed a comparable response to cold in the two groups during treatment. Three months later, however, warming time was significantly decreased (by 7 minutes: 25%) and warming rate increased (+ 22.4%) in group 1 (intergroup difference: p = 0.02). There was no difference between groups in the weekly number of attacks during treatment periods. In contrast there was a moderate increase in both groups in the winter months. There was no increase in the severity of the attacks nor in their duration. CONCLUSION: In this clinical trial, LDF evidenced positive effects of percutaneous application of natural CO2 gas on vasomotricity and vasomotion while CT test showed that patients who had received 18 days of CO2 adapted more easily to exposure to cold. Clinical improvement seems to be masked by winter weather conditions.
机译:背景:在法国罗亚特(Royat)的水疗中心进行了一项随机双盲单中心试验,该试验针对的是轻度雷诺现象(秋季和冬季每月一天发作一两次)的患者。在局部应用CO2时,通过激光多普勒血流(LDF)和计算机计时测温法(CT)量化血流动力学变化,并与常规临床参数进行比较。患者和方法:将患者随机分为18天的CO2(第1组)或9天的空气+ 9天的CO2(第2组)。将气体在恒定温度下施加到前臂上先前加湿的皮肤上。积极治疗的效果通过LDF进行测量,持续获益通过计算机计时测温法(CT测试)进行评估。根据每日发作次数以及发作的持续时间和严重程度,在四种情况下(治疗前,中,末,三个月后)进行临床评估。结果:LDF在CO2治疗期间显示出数字血流量(+ 41%)和血管舒张(+ 42%)显着增加,但安慰剂治疗无变化。 CT测试显示两组在治疗期间对感冒的反应相当。然而,三个月后,第1组的升温时间显着减少(减少了7分钟:25%),升温速率增加了(+ 22.4%)(组间差异:p = 0.02)。治疗期间每周发作的次数在两组之间没有差异。相反,在冬季,两组的人数都有适度增加。攻击的严重程度和持续时间都没有增加。结论:在该临床试验中,LDF证明了经皮应用天然CO2气体对血管舒张和血管运动的积极作用,而CT试验显示,接受18天CO2的患者更容易适应寒冷。冬季天气情况似乎掩盖了临床改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号